The Daily News - Article

Local News

Texas City COVID-19 patients receive hydroxychloroquine

By KATHRYN EASTBURN The Daily News​ ​ ​


A group of COVID-19 positive residents at a Texas City nursing home are being treated with the anti-malaria drug hydroxychloroquine, Texas Gov. Greg Abbott said Monday.

The drug has been the subject of controversy in recent weeks because of its debated effectiveness in combating COVID-19.

Twenty-seven of the residents infected with COVID-19 at The Resort at Texas City nursing home, 1720 N. Logan St., are being treated with hydroxychloroquine, said Dr. Robin Armstrong, the medical director at the Resort at Texas City.

The Galveston County Health District confirmed last week that 83 people at the residence, including residents and employees, had been diagnosed with COVID-19.

One of those residents had died as of Monday, officials said.

Hydroxychloroquine is an anti-malarial drug, often prescribed for the autoimmune disease lupus, that has shown in limited research some potential to speed recovery in coronavirus patients.

Abbott announced the nursing home’s use of the drug during a televised update about the state’s reaction to the coronavirus on Monday afternoon. The drug was being used to “determine whether or not it will be a successful treatment for those patients,” Abbott said.

The nursing home began using the treatment Saturday, Armstrong said.

Families of residents were not notified before the drugs were administered, but nursing home operators were in the process of notifying them Monday, Armstrong said.

The goal is to keep sicker, elderly patients out of the hospital, Armstrong said.

“I’m a hospitalist and have used it on hospitalized patients before,” he said. “For younger patients, it can have a benefit of helping them as they’re getting sicker.”

Elderly patients, once they are hospitalized, generally don’t recover and tend to do better staying in a familiar setting to be treated, Armstrong said.

Patients’ respiratory rates, temperatures and oxygen saturation levels are being measured regularly, he said. The drug will be administered over a course of five days, and by early next week he should be able to determine whether they are responding, he said.

Asked whether he was required to get permission from the Texas Department of State Health Services to administer hydroxychloroquine to COVID-19 patients, Armstrong said no.

“We just, as a group of health experts, we made the decision it would be safe and for their benefit,” he said. “These are not meds that are odd or unusual.”

“We’re just trying to treat them a little bit early,” he said. “We made the decision that if we can improve their survival, we’ll give it a try.”

The Galveston County Health District was not involved in the decision to use the drug in Texas City, a spokeswoman said.

The drug has been a source of controversy in recent weeks. President Donald Trump has promoted its use, while Dr. Anthony Fauci, the White House’s senior medical advisor, has argued that treatment using the drug has not been proven effective and that more rigorous study of the drug is still needed.

Still, the U.S. Food and Drug Administration has authorized the drug for “emergency use” among some COVID-19 patients “for whom a clinical trial is not feasible.”

— Material from The Texas Tribune was used in this report.

Social Media